GO:0019464 glycine decarboxylation via glycine cleavage system: Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019464 describes the oxidative breakdown of glycine into carbon dioxide, ammonia, and a methylene group, carried out by the glycine cleavage system (GCS).
• The GCS is a multienzyme complex composed of P-protein (GLDC), H-protein (GCSH), T-protein (GCST or AMT), and L-protein (DLD), and requires tetrahydrofolate and lipoic acid as cofactors.
• GCS activity is the major source of one-carbon units for folate metabolism and contributes to formate production in mitochondria.
• Defects in GCS cause non-ketotic hyperglycinemia, a life-threatening neonatal disorder characterized by elevated glycine in body fluids.
• GCS flux influences ischemic injury, pluripotency maintenance, and metabolic reprogramming, making it a target for disease and stem cell research.
• Quantitative methods such as stable-isotope infusions and genetic models enable precise measurement of glycine turnover and decarboxylation rates.
Description
Glycine decarboxylation via the glycine cleavage system (GO:0019464) is a fundamental mitochondrial pathway that catalyzes the oxidative cleavage of glycine into carbon dioxide, ammonia, and a methylene group transferred to tetrahydrofolate. This process is the primary route for glycine catabolism in many organisms and provides one-carbon units for nucleotide synthesis, methylation reactions, and formate production. The glycine cleavage system (GCS) is a multienzyme complex that includes four proteins: P-protein (glycine decarboxylase, GLDC), H-protein (glycine cleavage system protein H, GCSH), T-protein (aminomethyltransferase, AMT), and L-protein (dihydrolipoamide dehydrogenase, DLD). Because of its central role in one-carbon metabolism, the GCS is a subject of intense research in inherited metabolic disorders, cancer metabolism, and stem cell biology. Understanding GO:0019464 is therefore essential for researchers investigating mitochondrial metabolism, amino acid catabolism, and related diseases.
glycine decarboxylation via glycine cleavage system At A Glance
| GO ID | GO:0019464 |
|---|---|
| GO term | glycine decarboxylation via glycine cleavage system |
| Ontology | biological_process |
| Synonym | glycine cleavage system |
| Major function | Oxidative cleavage of glycine to CO2, NH3, and a methylene group, generating one-carbon units for folate metabolism |
| Cellular location | Mitochondrial matrix |
| Enzymes involved | P-protein (GLDC), H-protein (GCSH), T-protein (AMT), L-protein (DLD) |
| Cofactors | Pyridoxal phosphate, lipoic acid, tetrahydrofolate, NAD+ |
| Pathway context | Glycine, serine, and threonine metabolism; one-carbon metabolism |
What Is GO:0019464?
GO:0019464 is defined as the chemical reactions and pathways resulting in the breakdown of glycine by oxidative cleavage to carbon dioxide, ammonia, and a methylene group, mediated by enzymes of the glycine cleavage complex. This process is synonymous with the glycine cleavage system and occurs primarily in the mitochondria of eukaryotes and in bacteria.
Why Is glycine decarboxylation via glycine cleavage system Important in Cell Biology?
GO:0019464 is critical because it represents the main catabolic route for glycine and a major source of one-carbon units in mitochondria. Dysregulation of this pathway leads to severe metabolic disorders such as non-ketotic hyperglycinemia and influences outcomes in stroke, cancer, and stem cell differentiation. Thus, studying glycine decarboxylation provides insights into fundamental metabolic control and offers potential therapeutic targets.
• Mutations in GCS genes cause non-ketotic hyperglycinemia, a neonatal disorder with severe neurological symptoms.
• GCS-derived one-carbon units are essential for purine and thymidylate synthesis, linking the pathway to cell proliferation.
• The GCS modulates glycine concentrations, which affect neurotransmission and ischemic injury in the brain.
• Glycine decarboxylation supports pluripotency maintenance and induction in stem cells through metabolic control.
• Quantitative measurement of glycine turnover and decarboxylation rates is possible using stable isotope infusions.
• The GCS is a target for metabolic engineering and cancer therapy due to its role in one-carbon supply.
• Plant and cyanobacterial GCS complexes provide comparative insights into enzyme stoichiometry and evolution.
• The H-protein undergoes conformational changes that regulate the overall GCS reaction.
• GCS activity influences formate production, which is important for in vitro and in vivo metabolic tracing.
• Understanding GCS regulation can inform treatments for hyperglycinemia and related metabolic imbalances.
What Happens During glycine decarboxylation via glycine cleavage system?
Overview of the Glycine Cleavage System
In simple terms: The glycine cleavage system is a team of four proteins that work together to break down glycine into smaller molecules.
The glycine cleavage system (GCS) is a multienzyme complex that catalyzes the reversible oxidative cleavage of glycine. It consists of four components: P-protein (GLDC), H-protein (GCSH), T-protein (AMT), and L-protein (DLD). The overall reaction converts glycine, tetrahydrofolate (THF), and NAD+ into carbon dioxide, ammonia, 5,10-methylene-THF, and NADH. This process is the primary route for glycine catabolism in mitochondria and is conserved from bacteria to humans.
Step 1: Decarboxylation by P-protein
In simple terms: The first step removes carbon dioxide from glycine using a vitamin B6-dependent enzyme.
P-protein (glycine decarboxylase, GLDC) catalyzes the decarboxylation of glycine, releasing carbon dioxide and transferring the remaining methylene group to the lipoamide cofactor of H-protein. This step requires pyridoxal phosphate (PLP) as a cofactor. The reaction is the initial and rate-limiting step of the GCS.
Step 2: Methylene transfer and release by T-protein
In simple terms: The second step transfers the methylene group to a carrier molecule and releases ammonia.
T-protein (aminomethyltransferase, AMT) catalyzes the transfer of the methylene group from the lipoamide of H-protein to tetrahydrofolate (THF), forming 5,10-methylene-THF, and releases ammonia. This reaction is essential for generating one-carbon units for folate metabolism. The N-terminal region of T-protein is important for its function and interaction with H-protein.
Step 3: Regeneration of the lipoamide by L-protein
In simple terms: The third step recharges the carrier protein so it can participate in another round of cleavage.
L-protein (dihydrolipoamide dehydrogenase, DLD) reoxidizes the reduced lipoamide of H-protein using NAD+ as an electron acceptor, regenerating the oxidized form of H-protein and producing NADH. This step completes the catalytic cycle and allows the GCS to continue functioning.
Step 4: Conformational changes and regulation
In simple terms: The H-protein changes shape to help the other proteins do their jobs.
The H-protein undergoes conformational changes upon lipoamide modification that facilitate interactions with P-, T-, and L-proteins. Limited proteolysis studies have shown that the N-terminal region of T-protein is involved in these conformational transitions. These dynamic interactions are critical for the overall efficiency of the glycine cleavage system.
Key Genes Involved in GO:0019464 glycine decarboxylation via glycine cleavage system
The following genes encode the core components of the glycine cleavage system and associated regulatory factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GLDC | P-protein; decarboxylates glycine | Mutations cause non-ketotic hyperglycinemia; target in cancer metabolism |
| GCSH | H-protein; carries methylene group | Essential for GCS activity; mutations linked to hyperglycinemia |
| AMT | T-protein; transfers methylene to THF | Defects cause non-ketotic hyperglycinemia; studied for one-carbon metabolism |
| DLD | L-protein; reoxidizes lipoamide | Mutations cause E3 deficiency; role in GCS regeneration |
| MTHFD2 | Mitochondrial one-carbon metabolism | Supports GCS-derived formate production |
| SHMT2 | Serine hydroxymethyltransferase | Interconverts serine and glycine; linked to GCS flux |
| GLRX5 | Iron-sulfur cluster assembly | May affect lipoamide synthesis for GCS |
| LIAS | Lipoic acid synthase | Required for lipoamide cofactor of H-protein |
| PDHX | Pyruvate dehydrogenase complex component | Shares lipoamide chemistry with GCS |
| GCSH | H-protein; lipoamide-bearing | Conformational changes regulate GCS |
| AMT | T-protein; N-terminal region | Proteolysis studies reveal functional domains |
| GLDC | P-protein; PLP-dependent | Rate-limiting enzyme; target for inhibitors |
| DLD | L-protein; NAD+-dependent | Regenerates H-protein; linked to oxidative stress |
| MTHFR | Methylenetetrahydrofolate reductase | Impacts folate cycle downstream of GCS |
| MTHFD1L | Formate-tetrahydrofolate ligase | Produces formate from GCS-derived one-carbon units |
| ALDH1L2 | 10-formyltetrahydrofolate dehydrogenase | Regulates folate pool influenced by GCS |
| GART | Purine synthesis | Utilizes one-carbon units from GCS |
| TYMS | Thymidylate synthase | Requires 5,10-methylene-THF from GCS |
How Is glycine decarboxylation via glycine cleavage system Regulated?
The glycine cleavage system is regulated at multiple levels. In non-ketotic hyperglycinemia models, GCS activity and glycine conjugation pathways are coordinately regulated to maintain glycine homeostasis. The H-protein undergoes conformational changes that modulate enzyme interactions. Additionally, the pathway is influenced by the availability of cofactors such as pyridoxal phosphate, lipoic acid, and tetrahydrofolate. In stem cells, glycine decarboxylase activity is linked to pluripotency maintenance through metabolic control. Furthermore, ischemic injury alters extracellular glycine concentrations in mice with genetically altered GCS activity, indicating physiological regulation.
glycine decarboxylation via glycine cleavage system and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GLDC | Non-ketotic hyperglycinemia; cancer metabolism | GLDC knockout cell lines; patient-derived iPSCs |
| GCSH | Non-ketotic hyperglycinemia | GCSH point-mutation knock-in mice |
| AMT | Non-ketotic hyperglycinemia | AMT knockout zebrafish or mouse models |
| DLD | E3 deficiency; oxidative stress | DLD knockdown hepatocytes |
| GLDC | Stem cell pluripotency | GLDC overexpression in induced pluripotent stem cells |
Non-ketotic hyperglycinemia
Non-ketotic hyperglycinemia (NKH) is a life-threatening neonatal disorder caused by defects in the glycine cleavage system, leading to accumulation of glycine in blood, urine, and cerebrospinal fluid. Mutations in GLDC, GCSH, or AMT account for most cases. The disease presents with lethargy, seizures, and developmental delay, often leading to early death. Mouse models with altered GCS activity have been used to study glycine metabolism and conjugation pathways in NKH.
Ischemic stroke and neuroprotection
Glycine concentrations influence ischemic injury in the brain. Mice with genetically altered glycine cleavage system activity show a direct correlation between ischemic injury and extracellular glycine concentration, suggesting that GCS modulation could affect stroke outcomes. This links GO:0019464 to neuroprotective strategies.
Cancer metabolism and stem cell pluripotency
Glycine decarboxylase (GLDC) regulates the maintenance and induction of pluripotency via metabolic control, highlighting a role for the GCS in stem cell biology. In cancer, GCS-derived one-carbon units support nucleotide synthesis and proliferation, making the pathway a potential therapeutic target.
From glycine decarboxylation via glycine cleavage system-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GLDC loss affect glycine flux? | GLDC knockout HEK293 or HepG2 cells |
| How do GCS mutations cause NKH? | GCSH or AMT point-mutation knock-in mice |
| Can GCS activity be traced in vivo? | Stable isotope infusion in wild-type and mutant mice |
| Does GCS regulate pluripotency? | GLDC overexpression and knockout in mouse embryonic stem cells |
| What is the role of H-protein conformation? | Tagged knock-in of GCSH for structural studies |
| Does GCS modulation affect ischemic injury? | Mice with genetically altered GCS activity subjected to stroke models |
How to Study the glycine decarboxylation via glycine cleavage system Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Stable isotope infusion | Glycine turnover and decarboxylation rate | In vivo human and mouse metabolic studies |
| 13C tracing | Formate production from GCS | In vitro and in vivo mitochondrial metabolism |
| Enzyme activity assay | CO2 or NADH production by GCS | Recombinant protein or mitochondrial lysates |
| Limited proteolysis | Conformational changes in H-protein | Structural studies of GCS components |
| Metabolomics | Glycine, serine, and folate metabolites | Diagnosis of NKH and metabolic profiling |
| CRISPR knockout screen | Gene essentiality and synthetic lethality | Cancer and stem cell research |
| Western blot | Protein expression of GCS components | Validation of knockout or overexpression |
| qRT-PCR | mRNA levels of GLDC, GCSH, AMT, DLD | Gene expression analysis in disease models |
Stable isotope tracing
Primed, constant infusions of [1,2-13C2]glycine and [2H3]leucine allow quantification of glycine turnover and decarboxylation rates in vivo. This method has been used to measure GCS flux in healthy men and women. In vitro and in vivo tracing of mitochondrial GCS-derived formate can be performed using 13C-labeled glycine.
Genetic models and enzyme assays
Mouse models with genetically altered GCS activity are valuable for studying ischemic injury and glycine metabolism. Enzyme assays using isolated mitochondria or recombinant proteins can measure GCS activity by monitoring CO2 release or NADH production. Limited proteolysis and mass spectrometry can probe conformational changes in H-protein and T-protein.
Metabolomics and flux analysis
Metabolomic profiling of glycine, serine, and one-carbon metabolites in cells or tissues can reveal GCS dysfunction. Flux analysis using 13C-labeled substrates coupled with mass spectrometry quantifies pathway activity. These approaches are essential for understanding GCS contributions to folate metabolism.
CRISPR screening and functional genomics
CRISPR knockout screens targeting GCS genes can identify synthetic lethal interactions and metabolic dependencies. Such screens have been used to study pluripotency and cancer cell proliferation. Bioinformatics analysis of screen data can pinpoint pathways that compensate for GCS loss.
How CRISPR Can Be Used to Study GO:0019464 glycine decarboxylation via glycine cleavage system
Knockout
CRISPR knockout of GLDC, GCSH, AMT, or DLD can abolish glycine cleavage system activity, leading to glycine accumulation and altered one-carbon metabolism. Such knockouts are used to model non-ketotic hyperglycinemia and to study metabolic dependencies in cancer cells. Knockout cell lines can be validated by measuring glycine levels and GCS enzyme activity.
Point Mutation
Point mutations in GCS genes identified in NKH patients can be introduced using CRISPR base editing or homology-directed repair to create isogenic models. These models help dissect the functional impact of specific missense mutations on enzyme activity and protein stability. For example, mutations in the N-terminal region of T-protein affect its function.
Knock-in
Knock-in of tagged GCSH or GLDC (e.g., FLAG or GFP) enables affinity purification and imaging of the glycine cleavage system in live cells. Tagged knock-in models can also be used for structural studies and interaction proteomics. Knock-in of patient-specific mutations creates precise disease models.
Overexpression
Overexpression of GLDC or other GCS components can enhance glycine decarboxylation and one-carbon supply, supporting pluripotency maintenance in stem cells. Overexpression models are useful for studying the effects of increased GCS flux on cell proliferation and metabolism. They can also be used to test whether GCS activity is rate-limiting under specific conditions.
How EDITGENE Supports glycine decarboxylation via glycine cleavage system Research
Researchers studying glycine decarboxylation via glycine cleavage system-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease pathogenesis, or stem cell phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of GCS components and their regulators.
Contact EDITGENE today to design your custom CRISPR model for glycine decarboxylation via glycine cleavage system research.
Frequently Asked Questions About glycine decarboxylation via glycine cleavage system
What is glycine decarboxylation via glycine cleavage system?
It is the biological process (GO:0019464) that breaks down glycine into carbon dioxide, ammonia, and a methylene group using the glycine cleavage system.
What genes are involved in glycine decarboxylation via glycine cleavage system?
The core genes are GLDC (P-protein), GCSH (H-protein), AMT (T-protein), and DLD (L-protein).
What is the glycine cleavage system?
The glycine cleavage system is a multienzyme complex that catalyzes the oxidative cleavage of glycine and is synonymous with GO:0019464.
What diseases are associated with glycine cleavage system defects?
Defects cause non-ketotic hyperglycinemia, a severe neonatal disorder with neurological symptoms.
How is glycine decarboxylation measured?
It can be measured using stable isotope infusions of labeled glycine and mass spectrometry to quantify turnover and decarboxylation rates.
What cofactors are required for glycine cleavage?
The system requires pyridoxal phosphate, lipoic acid, tetrahydrofolate, and NAD+.
Does the glycine cleavage system produce one-carbon units?
Yes, it generates 5,10-methylene-THF, which is a key one-carbon donor for nucleotide synthesis and methylation.
Can CRISPR be used to study glycine cleavage system genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study GCS gene function.
What is the role of GLDC in cancer?
GLDC supports one-carbon metabolism and proliferation in cancer cells, making it a potential therapeutic target.
How does the glycine cleavage system affect stem cells?
Glycine decarboxylase activity regulates pluripotency maintenance and induction via metabolic control.
Conclusion
GO:0019464, glycine decarboxylation via the glycine cleavage system, is a central metabolic pathway with far-reaching implications for human health and disease. Its four-enzyme complex orchestrates the breakdown of glycine into one-carbon units, influencing folate metabolism, stem cell pluripotency, and neurological function. Defects in this pathway cause non-ketotic hyperglycinemia, and its dysregulation is linked to ischemic injury and cancer. Continued research using CRISPR models and advanced metabolomics will further illuminate the therapeutic potential of targeting the glycine cleavage system.
References
- 1. Tan YL et al.. 2020. Tracing Metabolic Fate of Mitochondrial Glycine Cleavage System Derived Formate In Vitro and In Vivo.. Int J Mol Sci 21(22) PMID: 33233834
- 2. Leung KY et al.. 2020. Regulation of glycine metabolism by the glycine cleavage system and conjugation pathway in mouse models of non-ketotic hyperglycinemia.. J Inherit Metab Dis 43(6):1186-1198 PMID: 32743799
- 3. Wittmiß M et al.. 2020. Stoichiometry of two plant glycine decarboxylase complexes and comparison with a cyanobacterial glycine cleavage system.. Plant J 103(2):801-813 PMID: 32311173
- 4. Oda M et al.. 2007. Direct correlation between ischemic injury and extracellular glycine concentration in mice with genetically altered activities of the glycine cleavage multienzyme system.. Stroke 38(7):2157-64 PMID: 17510459
- 5. Lamers Y et al.. 2007. Glycine turnover and decarboxylation rate quantified in healthy men and women using primed, constant infusions of [1,2-(13)C2]glycine and [(2)H3]leucine.. J Nutr 137(12):2647-52 PMID: 18029478
- 6. Kang PJ et al.. 2019. Glycine decarboxylase regulates the maintenance and induction of pluripotency via metabolic control.. Metab Eng 53:35-47 PMID: 30779965
- 7. Tada K et al.. 1992. Non-ketotic hyperglycinemia: a life-threatening disorder in the neonate.. Early Hum Dev 29(1-3):75-81 PMID: 1396281
- 8. Okamura-Ikeda K et al.. 2003. Probing the H-protein-induced conformational change and the function of the N-terminal region of Escherichia coli T-protein of the glycine cleavage system by limited proteolysis.. J Biol Chem 278(12):10067-72 PMID: 12531904
